Toosendanin, a triterpenoid derivative, acts as a novel agonist of L-type Ca 2+ channels in neonatal rat ventricular cells

European Journal of Pharmacology

Volumn 501, Issue 1-3, 2004, Pages 71-78

  Li, Mu Feng ^a   Shi, Yu Liang ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Agonist; L type Ca 2+ channel; Neonatal rat ventricular cell; Toosendanin; Whole cell patch clamp

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; BAYK 8644; CALCIUM CHANNEL L TYPE; TOOSENDANIN; TRITERPENOID; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; BAY REGION BINDING SITE; CALCIUM CURRENT; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRIC POTENTIAL; FLOW KINETICS; HEART MUSCLE CELL; HEART VENTRICLE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; STEADY STATE;

ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HEART VENTRICLES; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TRITERPENES;

EID: 4644260178     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.08.027     Document Type: Article

References (43)

1. A receptor-chloride channel complex T. Narahashi Methods in Neurosciences, Ion Channels of Excitable Cells 1994 Academic Press San Diego 148 156
2. G. Callewaert Excitation-contraction coupling in mammalian cardiac cells Cardiovasc. Res. 26 1992 923 927
3. C.C. Chang, T.H. Hsie, S.F. Chen, and H.T. Liang The structure of Chuanliansu Acta Chim. Sin. 33 1975 35 47
4. W.Y. Chen, P.B. Yin, W.L. Ye, and Y.L. Shi Toosendanin-induced change of dopamine level detected by microdialysis in vivo at rat striatum Chin. Sci. Bull. 44 1999 502 506
5. T. Chijiwa, A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-Bromocinnamylamino)ethyl]-5- isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells J. Biol. Chem. 265 1990 5267 5272
6. N.M. Cohen, and W.J. Lederer Calcium current in isolated neonatal rat ventricular myocytes J. Biol. Chem. 391 1987 169 191
7. 2+ currents in mouse and frog motor nerve terminals Neurosci. Res. 41 2001 243 249
8. X.D. Gao, S.B. Tang, J. Lu, and Y.L. Shi Effects of toosendanin on electric and mechanical properties of guinea pig papillary muscles Zhongguo Yaoli Xuebao 15 1994 147 151
9. J.P. Gomez, D. Potreau, J.E. Branka, and G. Raymond Developmental changes in calcium currents from newborn rat cardiomyocytes in primary culture Pflügers Arch. 428 1994 241 249
10. J.P. Gomez, N. Fares, and D. Potreau Effects of BayK8644 on L-type calcium current from newborn rat cardiomyocytes in primary culture J. Mol. Cell. Cardiol. 28 1996 2217 2229
11. S.L. Hamilton, and M. Perez Toxins that affect voltage-dependent calcium channels Biochem. Pharmacol. 36 1987 3325 3329
12. S.L. Hamilton, A. Yatani, K. Brush, A. Schwartz, and A.M. Brown A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes Mol. Pharmacol. 31 3 1987 221 231
13. P. Hess, J.B. Lansman, and R.W. Tsien Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists Nature 311 1984 538 544
14. Q. Hu, F.S. Huang, and Y.L. Shi Inhibition of toosendanin on the delayed rectifier potassium current in neuroblastomaxglioma NG108-15 cells Brain Res. 751 1997 47 53
15. A.M. Katz Molecular biology of calcium channels in the cardiovascular system Am. J. Cardiol. 80 9A 1997 171 221
16. 2+ channels. Evidence for an agonistic action J. Biol. Chem. 265 1990 1156 1166
17. S. Kokubun, and H. Reuter Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells Proc. Natl. Acad. Sci. U. S. A. 81 1984 4824 4827
18. P.Z. Li, J. Zhou, W.Y. Miao, F.H. Ding, J.Y. Meng, G.R. Jia, J.F. Li, H.J. Ye, X.Y. He, M.Y. Chen, and Z.M. Huang Therapeutic effect of toosendanin on animal botulism Chin. Tradit. Herb. Drugs 13 1982 28 30
19. 2+ current in NG108-15 cells via L-type channels Neurosci. Res. 49 2004 197 203
20. 2+ channel activators, (S)-Bay K 8644 and FPL 64176, in smooth muscle Mol. Pharmacol. 41 1992 599 602
21. D. Rampe, and A.E. Lacerda A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176 J. Pharmacol. Exp. Ther. 259 1991 982 987
22. 2+ channels in rat tail artery smooth muscle cells Br. J. Pharmacol. 135 2002 1819 1827
23. Y.L. Shi, and W.Y. Chen Effect of toosendanin on acetylcholine level of rat brain, a microdialysis study Brain Res. 850 1999 173 178
24. Y.L. Shi, and K. Xu Antibotulismic effect of toosendanin Chin. Sci. Bull. 28 1983 885 887
25. Y.L. Shi, and K. Xu Anti-botulismic effect of toosendanin and its facilitatory action on miniature end-plate potentials Jpn. J. Physiol. 33 1983 677 680
26. Y.L. Shi, N.S. Wei, Y.Q. Yang, and Z.X. Wang Toosendanin - a presynaptic neuromuscular blocking agent Acta Physiol. Sin. 32 1980 293 297
27. Y.L. Shi, W.P. Wang, and K. Xu Electrophysiological analysis on the presynaptic blocking effects of toosendanin on neuromuscular transmission Acta Physiol. Sin. 33 1981 259 265
28. 2+ on onset of toosendanin paralysis of isolated neuromuscular preparations Acta Physiol. Sin. 33 1981 141 146
29. G.X. Shu, and X.T. Liang A correction of the structure of Chuanliansu Acta Chim. Sin. 38 1980 196 198
30. ++ channels of myocardial cells Mol. Cell. Biochem. 163/164 1996 85 98
31. K. Sumii, and N. Sperelakis Cyclic GMP-dependent protein kinase regulation of the L-type calcium current in neonatal rat ventricular myocytes Circ. Res. 77 1995 803 812
32. M.Z. Tang, Z.F. Wang, and Y.L. Shi Toosendanin induces outgrowth of neuronal processes and apoptosis in PC12 cells Neurosci. Res. 45 2003 225 231
33. + channels in hippocampal neurons by toosendanin Neuroscience 104 2001 41 47
34. Z.F. Wang, and Y.L. Shi Toosendanin-induced inhibition of small-conductance calcium-activated potassium channels in CA1 pyramidal neurons of rat hippocampus Neurosci. Lett. 303 2001 13 16
35. Z.F. Wang, and Y.L. Shi Modulation of inward rectifier potassium channel by toosendanin, a presynaptic blocker Neurosci. Res. 40 2001 211 215
36. Y.B. Wang, and Y.X. Wen A comprehensive report on clinical ascaris anthelmintic therapeutic effect of Toosendanin pills J. Tradit. Chin. Med. 262 1959 46 49
37. R. Wang, E. Karpinski, and P.K. Pang Two types of calcium channels in isolated smooth muscle cells from rat tail artery Am. J. Physiol. 256 1989 H1361 H1368
38. Z. Xiong, and N. Sperelakis Regulation of L-type calcium channels of vascular smooth muscle cells J. Mol. Cell. Cardiol. 27 1995 75 91
39. Y.F. Xu, and Y.L. Shi Action of Toosendanin on the membrane current of mouse motor nerve terminals Brain Res. 631 1993 46 50
40. +-evoked glutamate release from rat synaptosomes by toosendanin 6th Chin Congr. Biol. Toxin, Changsha 2003 P39
41. 2+ channels Acta Pharmacol. Sin. 25 2004 597 601
42. 2+ channel activator, in cardiac and vascular preparations Mol. Pharmacol. 40 1991 734 741
43. J.Y. Zhou, Z.F. Wang, X.M. Ren, M.Z. Tang, and Y.L. Shi Antagonism of botulism toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin FEBS Lett. 555 2003 375 379